Navigation Links
Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS
Date:12/13/2007

of SOD1 extended survival of rats that show many features of ALS. The ALS Association and the Muscular Dystrophy Association are providing funding for IND-enabling studies of ISIS 333611.

About Orphan Drug Designation

The Orphan Drug Act provides for economic incentives to encourage the development of drugs for diseases affecting fewer than 200,000 people in the United States. Orphan drug designation entitles Isis Pharmaceuticals to seven years of U.S. market exclusivity for ISIS 333611 for the treatment of patients with familial ALS.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 18 drugs in development. Isis' drug development programs are focused on treating cardiovascular and metabolic diseases. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Ibis Biosciences, Inc., Isis' wholly owned subsidiary, is developing and commercializing the Ibis T5000(TM) Biosensor System, a revolutionary system to identify infectious organisms. Isis is a joint owner of Regulus Therapeutics LLC, a joint venture focused on the discovery, development and commercialization of microRNA therapeutics. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,500 issued patents worldwide. Additional information about Isis is available at http://www.isispharm.com.

This press release includes forward-looking statements regarding the development, therapeutic potential and safety of ISIS 333611. Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement, including those statements that are descr
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... NY (PRWEB) May 05, 2015 ... honors Irene Taylor , Volunteer Executive ... as a 2015-2016 inductee into its VIP Woman ... this prestigious distinction for leadership in business. NAPW ... professional women, boasting more than 700,000 members and ...
(Date:5/4/2015)... City, NY (PRWEB) May 05, 2015 ... honors Jennifer Yates Doherty as a 2015-2016 ... Circle. She is recognized with this prestigious distinction for ... organization exclusively for professional women, boasting more than 700,000 ... pleased to welcome Jennifer into this exceptional group of ...
(Date:5/4/2015)... (PRWEB) May 05, 2015 The ... Shirley Weis as a 2015-2016 inductee into its ... with this prestigious distinction for leadership in healthcare. NAPW ... women, boasting more than 700,000 members and over 200 ... with this important honor,” says NAPW President Star Jones. ...
(Date:5/4/2015)... 04, 2015 The American Council ... Thomopulos, P.E., Chairman of Stanley Consultants , to ... of directors for a three-year term. , ACEC co-established ... the American Society of Civil Engineers (ASCE). A ... system for civil infrastructure called Envision. Launched in 2012, ...
(Date:5/4/2015)... HHT is a rare but cruel and unrelenting ... have seemingly mild symptoms like frequent nosebleeds, it can ... Telangiectasia (HHT) is a hereditary disorder resulting in the ... between an artery and a vein. These abnormalities in ... also be present in the lungs, brain and liver. ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Irene Taylor into its 2015-2016 VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Jennifer Yates Doherty, Owner of Palmetto Rehabilitation Services, LLC, into its 2015 VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Shirley Weis, President at Weis Associates, LLC, into its 2015-2016 VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Shirley Weis, President at Weis Associates, LLC, into its 2015-2016 VIP Woman of the Year Circle 3Health News:Thomopulos Appointed to Institute for Sustainable Infrastructure Board 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 3
... fetal surgery and the cause of heated debate among ... the best way to treat twin-twin transfusion syndrome (TTTS), ... and the leading cause of mortality in twins? ... 17 centers in the United States, will be presented ...
... gift that brought tears to the receiver and to the ... was pledged to the staff at Toronto’s Hospital for Sick Children ... of a beer baron and well-established friend of the hospital. ... mutual fund company and his wife Sonia, have pledged this amount ...
... to the flu, in British Columbia//. , The flu season ... of December and January. ,This unusually long delay may ... Theresa Tam of the Public Health Agency of Canada, in an average ... year that can go up to six to eight thousand. ...
... hospitals with a fewer infection and death rates is announced ... method// has been tried out successfully in United States. This ... of society. ,The incentive scheme initially is set ... knee replacements. In case of very sick patients and severe ...
... is a complex and common disease caused by a ... research shows that the constitutional mutation in PALB2 gene ... ,Previous studies have shown that genes are responsible for ... breast cancer. The two major familial breast cancer susceptibility ...
... unique weaving machine of their design, Duke University Medical ... could greatly improve the ability of physicians to repair ... ,"If further experiments are successful, the scaffold ... four years," said Franklin Moutos, a graduate student in ...
Cached Medicine News:Health News:Timeliness, a Critical Factor in Treating TTTS 2Health News:Timeliness, a Critical Factor in Treating TTTS 3Health News:Record Donation to Children’s Hospita 2Health News:Flu Strikes Late - Child Succumbs 2Health News:Mutation In PALB2 Elevates Risk of Cancer 2Health News:Woven Cartilage 2
(Date:5/4/2015)... Former NASA scientist Tamim Hamid ... he discussed Theradome™, the first portable and wearable OTC ... shows firsthand how, via laser technology, Theradome™ offers individuals ... will not require surgery or medication.  ... of the hair follicle, which is where the stem ...
(Date:5/4/2015)... PAREXEL International Corporation (NASDAQ: PRXL ) announced ... Conference on Monday, May 18, 2015, in New York City.  ... Officer will be making a presentation on PAREXEL and discussing ... webcast of the presentation will be available through the "Investors" ... Upcoming Events portion of the main page, and a replay ...
(Date:5/4/2015)... May 4, 2015 Rogne Bioscience, a privately-held ... announced that preclinical and mechanism of action data will ... of Investigative Dermatology (SID) Annual Meeting being held May ... Atlanta, Georgia . Logo - http://photos.prnewswire.com/prnh/20150501/213318LOGO ... of RON2315, a novel, low MW (<1700 daltons) peptide ...
Breaking Medicine Technology:FOX News Features Theradome as the Take-Home Solution to Tackle Baldness 2PAREXEL International to Present at UBS Healthcare Conference 2Rogne Bioscience to Present Data from Topical Biologic Psoriasis Program at Upcoming SID Annual Meeting 2015 2
... U.S. Food and Drug Administration today announced steps to ... devices that can lead to the transmission of disease. ... Medical devices intended for repeated use are commonplace ... durable substances that can withstand reprocessing, a multistep process ...
... (NASDAQ: KOOL ), a leading supplier of innovative ... will report financial results for the fiscal third quarter ended March ... Company,s Conference Call and Webcast Management ... PM Pacific (5:00 PM Eastern) to review the fiscal third quarter ...
Cached Medicine Technology:FDA Looks to Improve Design and Cleaning Instructions for Reusable Medical Devices 2FDA Looks to Improve Design and Cleaning Instructions for Reusable Medical Devices 3ThermoGenesis Corp. to Announce Third Quarter Fiscal 2011 Results On May 5, 2011 2
... Esprit is an internationally known ... youthful image. The ophthalmic collection offers ... originality and creativity in titanium, metal ... line features unique styling with trendy ...
The license agreement for the manufacturing and distribution of Bulgari eyewear was signed by Luxottica Group in 1997.,Bulgari eyewear is designed for sleek, select people who want to distinguish the...
... collection features classic designs paired with modern, ... range of materials including ultra-light titanium to ... as ovals, almonds and squares. Three-piece mounts ... The sun wear collection is the perfect ...
The Aristar collection offers high quality, fashionable eyewear at exceptional pricing. Classic shapes updated with contemporary designs allow both men and women alike to enjoy superior craftsmanship...
Medicine Products: